The News Feed

Pharmaceuticals

Data Reveals Impact of Ocular Adverse Events During Cancer Therapy

Study finds higher frequency of anterior segment problems and links certain ones, including neuro-ophthalmic and corneal issues, to reduced survival, highlighting the need for collaborative management strategies.
September 19, 2024

MD Groups Respond to Study Linking GLP-1 Treatment to NAION

The American Academy of Ophthalmology and North American Neuro-Ophthalmology Society stress that more research is needed to determine whether the association is causal.
July 11, 2024

Fluoroquinolone Use Not Linked to Increased Uveitis, Retinal Detachment Risk

Although an association with this antibiotic treatment cannot be completely ruled out, any absolute effect would be small.
May 31, 2024

Statin Use, Certain Ethnicities Linked to Late-Onset AMD

On the flip side, female sex, obesity and fluoxetine use were found to be associated with earlier development.
March 17, 2023

Topical NSAID Can Play a Role in Mild DME

This small study found it may reduce CST in patients with good glycemic control.
November 10, 2022

Mild Thyroid Eye Disease May Respond to Doxycycline

More work still needs to be done, though, as the drug’s improvement rate was fairly low.
October 4, 2022

ImprimisRx Launches Compounded Antibiotic and Product Replacement Program

The company says it’ll replace the formulation—marketed as Fortisite—when expired, at no cost.
October 3, 2022

Large Study Identifies Drug Associations with Angle Closure; Added Risk in Question

Some of these were already documented, but newly identified ones included drugs for constipation and nausea.
September 27, 2022

Hypotensive Drugs Impact Clarity of Intraocular Lenses

Additional investigation is needed to further clarify this correlation and its clinical implications.
September 12, 2022

Even Small Financial Incentives Influence Prescribing Habits

Reported receipt of any non-research support from pharmaceutical manufacturers, regardless of amount, was associated with an almost doubled probability of a prostaglandin drug Rx.
August 2, 2022